Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Infants and young children who had COVID produced protective antibodies for much longer than adults.
Study findings identify a potential marker that could help identify people at high risk of developing long COVID.
Antibodies crossed the placenta, likely conferring some protection for newborns immediately after birth.
A molecular decoy that neutralizes the SARS-CoV-2 virus by preventing it from latching onto cells protected mice against COVID-19.
The findings provide a basis for future studies of the immune system’s role in longevity.
NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.
A single vaccine dose delivered to nose aims to protect children and adults against COVID.
Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.
Cancer patients undergoing treatment and those with suppressed immune systems eye the future—and the COVID pandemic’s wane—warily.
Studies evaluate the impact of COVID-19 infection, treatments and vaccination in this uniquely vulnerable population.
The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.
The findings could have implications for vaccines against other rapidly evolving pathogens, such as influenza virus or SARS-CoV-2.
Evidence is growing that contracting SARS-CoV-2 is generally as effective as vaccination at preventing COVID-19.
People who received the Moderna COVID-19 vaccine had strong immune memory of SARS-CoV-2 six months after vaccination.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.